AMG 925 Is a Dual FLT3/CDK4 Inhibitor with the Potential to Overcome FLT3 Inhibitor Resistance in Acute Myeloid Leukemia
Cong Li(Tianjin Stomatological Hospital), Kang Dai(Amgen (United States)), Alexander Kamb(Integrated BioTherapeutics (United States)), Katie Newhall(Immunome (United States)), Angus M. Sinclair(LabGenius (United Kingdom)), Dineli Wickramasinghe(Amgen (United States)), Zhihong Li(Central South University), Zhen Xia(Amgen (United States)), Lingming Liang(Amgen (United States)), Lawrence R. McGee(Amgen (United States)), Xianghong Wang(Hebei Agricultural University), Liqin Liu(Xinjiang Agricultural University)
Cited by 38
Related Papers
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
|Nature Genetics|1994|850
Houttuynia-derived nitrogen-doped hierarchically porous carbon for high-performance supercapacitor
|Carbon|2020|432
Effectiveness of N95 respirators versus surgical masks against influenza: A systematic review and meta‐analysis
|Journal of Evidence-Based Medicine|2020|356
Time‐Resolved FRET Biosensor Based on Amine‐Functionalized Lanthanide‐Doped NaYF<sub>4</sub> Nanocrystals
|Angewandte Chemie International Edition|2011|328
Breakdown of Crystallographic Site Symmetry in Lanthanide‐Doped NaYF<sub>4</sub> Crystals
|Angewandte Chemie International Edition|2012|270